Clear Street’s Revelation Biosciences Warrant REVBW Stock Holding History

Clear Street’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95K	Sell	246,934 -600	-0.2%	-$6	﹤0.01%	1298
2026 Q1	$0	Buy	247,534 +200	+0.1%	+$2	﹤0.01%	1156
2025 Q4	$1.98K	Sell	247,334 -100	-0%	-$1	﹤0.01%	851
2025 Q3	$3.09K	Sell	247,434 -150	-0.1%	-$2	﹤0.01%	741
2025 Q2	$2.97K	Buy	+247,584	New	+$3K	﹤0.01%	575
2024 Q4	–	Sell	-100	Closed	-$2	–	621
2024 Q3	$2	Sell	100 -100	-50%	-$1	﹤0.01%	714
2024 Q2	$4	Buy	+200	New	+$3	﹤0.01%	791
2023 Q4	–	Sell	-100	Closed	-$2	–	922
2023 Q3	$2	Buy	+100	New	+$2	﹤0.01%	1109

Other funds holding REVBW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clear Street's REVBW Position: Q2 2026 in Review

Clear Street reduced its Revelation Biosciences Warrant (REVBW) stake by 0.24% in Q2 2026, selling an estimated $6 and leaving 246,934 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

Clear Street first reported a position in REVBW in Q3 2023 and has held it in 8 quarters since. The position peaked at $3.09K in Q3 2025. 13 funds tracked by Wall St. Rank hold REVBW as of Q2 2026.

Clear Street held 246,934 shares of Revelation Biosciences Warrant worth $1.95K as of Q2 2026.
Clear Street sold 600 Revelation Biosciences Warrant shares in Q2 2026, an estimated $6.
Revelation Biosciences Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1298 holding.
Clear Street first reported a position in Revelation Biosciences Warrant in Q3 2023 and has held it in 8 quarters since.
Clear Street's Revelation Biosciences Warrant position peaked at $3.09K in Q3 2025.
13 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.